← FDA DRUG APPROVALS

FDA NDA · NDA019005

BRETYLIUM TOSYLATE IN DEXTROSE 5%

Sponsor: ABBOTT

APPLICATION
NDA019005
TYPE
NDA
ORIGINAL APPROVAL
1986-04-16
LATEST ACTION
1986-04-16
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

BRETYLIUM TOSYLATE IN DEXTROSE 5%Discontinued
BRETYLIUM TOSYLATE 200MG/100ML · INJECTABLE · INJECTION
BRETYLIUM TOSYLATE IN DEXTROSE 5%Discontinued
BRETYLIUM TOSYLATE 400MG/100ML · INJECTABLE · INJECTION
BRETYLIUM TOSYLATE IN DEXTROSE 5%Discontinued
BRETYLIUM TOSYLATE 800MG/100ML · INJECTABLE · INJECTION

Approval history

1986-04-16Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →